[
  {
    "ts": null,
    "headline": "MoonLake Immunotherapeutics: Mid-2025 Sonelokimab HS Data Could Be Enhanced Upon",
    "summary": "MoonLake Immunotherapeutics is set to release results from both the phase 3 VELA-1 and VELA-2 studies in mid-2025. Click here to read why MLTX is a Strong Buy.",
    "url": "https://finnhub.io/api/news?id=99ba917a1d81d5a66e2bd5f86068fccb4f00de175a45a15b629998787f2025a3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737136997,
      "headline": "MoonLake Immunotherapeutics: Mid-2025 Sonelokimab HS Data Could Be Enhanced Upon",
      "id": 132417228,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2164156001/image_2164156001.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "MoonLake Immunotherapeutics is set to release results from both the phase 3 VELA-1 and VELA-2 studies in mid-2025. Click here to read why MLTX is a Strong Buy.",
      "url": "https://finnhub.io/api/news?id=99ba917a1d81d5a66e2bd5f86068fccb4f00de175a45a15b629998787f2025a3"
    }
  },
  {
    "ts": null,
    "headline": "Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks",
    "summary": "Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks",
    "url": "https://finnhub.io/api/news?id=2f63261d896407b0b28b62ebe819868ef49cb4ee09403d55be369318e2f50d37",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737122146,
      "headline": "Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks",
      "id": 132458798,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks",
      "url": "https://finnhub.io/api/news?id=2f63261d896407b0b28b62ebe819868ef49cb4ee09403d55be369318e2f50d37"
    }
  },
  {
    "ts": null,
    "headline": "Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out.",
    "summary": "Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out.",
    "url": "https://finnhub.io/api/news?id=328bc6fffa4a6f7b3aec17beb326850f0b0b2aeaf512fc90c051feec96e90632",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737111960,
      "headline": "Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out.",
      "id": 132458823,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Medicare Will Pay Less for Ozempic and Wegovy in 2027. The Price-Negotiation List Is Out.",
      "url": "https://finnhub.io/api/news?id=328bc6fffa4a6f7b3aec17beb326850f0b0b2aeaf512fc90c051feec96e90632"
    }
  }
]